Patents by Inventor Donggou He

Donggou He has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL FELINE ERYTHROPOIETIN RECEPTOR AGONISTS
    Publication number: 20190248858
    Abstract: The present specification discloses erythropoietin receptor agonists, compositions and medicaments comprising such erythropoietin receptor agonists, methods and uses for such erythropoietin receptor agonists and compositions and medicaments, and methods and uses for erythropoietin receptor agonists and compositions and medicaments for treating an anemia.
    Type: Application
    Filed: April 30, 2019
    Publication date: August 15, 2019
    Applicant: AskGene Pharma Inc.
    Inventors: Jian-Feng Lu, Yuefeng Lu, Aijun Wang, Donggou He, Kurt Shanebeck, Chen Yao
  • Feline erythropoietin receptor agonists
    Patent number: 10287336
    Abstract: The present specification discloses erythropoietin receptor agonists, compositions and medicaments comprising such erythropoietin receptor agonists, methods and uses for such erythropoietin receptor agonists and compositions and medicaments, and methods and uses for erythropoietin receptor agonists and compositions and medicaments for treating an anemia.
    Type: Grant
    Filed: September 17, 2015
    Date of Patent: May 14, 2019
    Assignee: AskGene Pharma, Inc.
    Inventors: Jian-Feng Lu, Yuefeng Lu, Aijun Wang, Donggou He, Kurt Shanebeck, Chen Yao
  • PD-L1 Specific Monoclonal Antibodies for Disease Treatment and Diagnosis
    Publication number: 20190106494
    Abstract: The present invention relates to compositions and methods for immunotherapy of a subject afflicted with diseases such as cancer, an infectious disease, or a neurodegenerative disease, which methods comprise administering to the subject a composition comprising a therapeutically effective amount of an anti-PD-L1 antibody or portion thereof that potentiates an endogenous immune response, either stimulating the activation of the endogenous response or inhibiting the suppression of the endogenous response.
    Type: Application
    Filed: August 23, 2018
    Publication date: April 11, 2019
    Applicants: AskGene Pharma Inc., Jiangsu AoSaiKang Pharmaceutical Co., Ltd.
    Inventors: Aijun Wang, Kurt Shanebeck, Donggou He, Chen Yao, Lu Li, Fang Xia, Yuefeng Lu, Jian-Feng Lu, Lan Yang
  • PD-L1 specific monoclonal antibodies for disease treatment and diagnosis
    Patent number: 10077308
    Abstract: The present invention relates to compositions and methods for immunotherapy of a subject afflicted with diseases such as cancer, an infectious disease, or a neurodegenerative disease, which methods comprise administering to the subject a composition comprising a therapeutically effective amount of an anti-PD-L1 antibody or portion thereof that potentiates an endogenous immune response, either stimulating the activation of the endogenous response or inhibiting the suppression of the endogenous response.
    Type: Grant
    Filed: June 12, 2017
    Date of Patent: September 18, 2018
    Assignees: AskGene Pharma Inc., Jiangsu AoSaiKang Pharmaceutical Co., Ltd.
    Inventors: Aijun Wang, Kurt Shanebeck, Donggou He, Chen Yao, Lu Li, Fang Xia, Yuefeng Lu, Jian-Feng Lu, Lan Yang
  • PD-L1 Specific Monoclonal Antibodies for Disease Treatment and Diagnosis
    Publication number: 20170355770
    Abstract: The present invention relates to compositions and methods for immunotherapy of a subject afflicted with diseases such as cancer, an infectious disease, or a neurodegenerative disease, which methods comprise administering to the subject a composition comprising a therapeutically effective amount of an anti-PD-L1 antibody or portion thereof that potentiates an endogenous immune response, either stimulating the activation of the endogenous response or inhibiting the suppression of the endogenous response.
    Type: Application
    Filed: June 12, 2017
    Publication date: December 14, 2017
    Applicants: AskGene Pharma Inc., Jiangsu AoSaiKang Pharmaceutical Co., Ltd.
    Inventors: Aijun Wang, Kurt Shanebeck, Donggou He, Chen Yao, Lu Li, Fang Xia, Yuefeng Lu, Jian-Feng Lu, Lan Yang
  • Novel Feline Erythropoietin Receptor Agonists
    Publication number: 20160083444
    Abstract: The present specification discloses erythropoietin receptor agonists, compositions and medicaments comprising such erythropoietin receptor agonists, methods and uses for such erythropoietin receptor agonists and compositions and medicaments, and methods and uses for erythropoietin receptor agonists and compositions and medicaments for treating an anemia.
    Type: Application
    Filed: September 17, 2015
    Publication date: March 24, 2016
    Applicant: AskGene Pharma, Inc.
    Inventors: Jian-Feng Lu, Yuefeng Lu, Aijun Wang, Donggou He, Kurt Shanebeck, Chen Yao